Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impacts of climate-induced hydro-meteorological hazards on women's reproductive and maternal health in India: An assessment of gender-based violence across stages of women's lives.

The journal of climate change and health·2026
Same author

Collaborative innovations and strategic directions in public health education: Insights from a round table discussion.

Journal of family medicine and primary care·2026
Same author

Tackling the global health research financing emergency to sustain national health research ecosystems.

Lancet (London, England)·2026
Same author

Setting research priorities to understand and address the impact of climate change on the health of women and children in low-income and middle-income countries using the Child Health and Nutrition Research Initiative method.

The Lancet. Global health·2026
Same author

Asia Pacific perspectives on global health architecture reform.

Nature medicine·2026
Same author

Delivering on a citizen-centred health system for India.

Lancet (London, England)·2026

Related Experiment Video

Updated: Jun 13, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Pediatric tuberculosis: global overview and challenges.

Soumya Swaminathan1, Banu Rekha

  • 1Tuberculosis Research Centre, Chennai, India. doctorsoumya@yahoo.com

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|April 20, 2010
PubMed
Summary
This summary is machine-generated.

Pediatric tuberculosis (TB) is a global child health crisis, yet children with TB are overlooked. Urgent research is needed for better diagnostics, treatments, and vaccines for drug-susceptible and drug-resistant TB in children.

Related Experiment Videos

Last Updated: Jun 13, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Area of Science:

  • Pediatric infectious diseases
  • Global child health
  • Tuberculosis research

Background:

  • Tuberculosis (TB) remains a leading cause of death in children globally, disproportionately affecting them despite its prevalence.
  • Children with TB are often marginalized in national health programs, receiving inadequate attention and resources.
  • Existing diagnostic tools and treatments for TB have not been adequately adapted or validated for pediatric use.

Purpose of the Study:

  • To highlight the critical neglect of pediatric tuberculosis in global health initiatives.
  • To identify key research gaps in pediatric TB diagnostics, treatment, and prevention.
  • To emphasize the need for multicenter trials to advance pediatric TB care.

Main Methods:

  • Review of current challenges in pediatric TB diagnosis and treatment.
  • Analysis of the status of pediatric drug formulations and vaccine efficacy.
  • Examination of complexities in managing HIV-coinfected children with TB.

Main Results:

  • Diagnostic advancements for adult TB are not validated in children.
  • Development of pediatric TB drugs and formulations is significantly lagging.
  • Optimal management strategies for HIV-coinfected children with TB require further investigation.

Conclusions:

  • Multicenter trials are essential to develop improved diagnostic strategies for pediatric TB.
  • There is an urgent need for shorter, safer, and more effective treatment regimens for drug-susceptible and drug-resistant TB in children.
  • Further research is required to optimize TB prevention and treatment in vulnerable pediatric populations, including those coinfected with HIV.